|
1
|
Fassnacht M, Kreissl MC, Weismann D and
Allolio B: New targets and therapeutic approaches for endocrine
malignancies. Pharmacol Ther. 123:117–141. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Urken ML: Management of
well-differentiated thyroid cancer in 2010: perspectives of a head
and neck surgical oncologist. Endocr Pract. 16:903–912. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kapur U and Wojcik EM: Follicular neoplasm
of the thyroid-vanishing cytologic diagnosis? Diagn Cytopathol.
35:525–528. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Freitas BC and Cerutti JM: Genetic markers
differentiating follicular thyroid carcinoma from benign lesions.
Mol Cell Endocrinol. 321:77–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Clausen T, Southan C and Ehrmann M: The
HtrA family of proteases implications for protein composition and
cell fate. Mol Cell. 10:443–455. 2002.PubMed/NCBI
|
|
6
|
Zurawa-Janicka D, Skorko-Glonek J and
Lipińska B: HtrA proteins as targets in therapy of cancer and other
diseases. Expert Opin Ther Targets. 14:665–679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chien J, Campioni M, Shridhar V and Baldi
A: HtrA serine proteases as potential therapeutic targets in
cancer. Curr Cancer Drug Targets. 9:451–468. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zumbrumm J and Treub B: Primary structure
of a putative serine protease specific for IGF-binding proteins.
FEBS Lett. 398:187–192. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baldi A, De Luca A, Morini M, Battista T,
Felsani A, Baldi F, Catricala C, Amantea A, Noonan DM, Albini A, et
al: The HtrA1 serine protease is down-regulated during human
melanoma progression and represses growth of metastatic melanoma
cells. Oncogene. 21:6684–6688. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chien J, Staub J, Hu SI, Erickson-Johnson
MR, Couch FJ, Smith DI, Crowl RM, Kaufmann SH and Shridhar V: A
candidate tumor suppressor HtrA1 is down-regulated in ovarian
cancer. Oncogene. 23:1636–1644. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chien J, Aletti G, Baldi A, Catalano V,
Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, et
al: Serine protease HtrA1 modulates chemotherapy-induced
cytotoxicity. J Clin Invest. 116:1994–2004. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Narkiewicz J, Klasa-Mazurkiewicz D,
Zurawa-Janicka D, Skorko-Glonek J, Emerich J and Lipińska B:
Changes in expression of human HtrA1, HtrA2 and
HtrA3 genes in ovarian cancer. Clin Biochem. 41:561–569.
2008.
|
|
13
|
Bowden MA, Di Nezza-Cossens LA, Jobling T,
Salamonsen LA and Nie G: Serine proteases HtrA1 and HtrA3 are
down-regulated with increasing grades of human endometrial cancer.
Gynecol Oncol. 103:253–260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Narkiewicz J, Lapińska-Szumczyk S,
Zurawa-Janicka D, Skorko-Glonek J, Emerich J and Lipińska B:
Expression of human HtrA1, HtrA2, HtrA3 and
TGF-β1 genes in primary endometrial cancer. Oncol Rep.
21:1529–1537. 2009.
|
|
15
|
Esposito V, Campioni M, De Luca A,
Spugnini EP, Baldi F, Cassandro R, Mancini A, Vincenzi B, Groeger
A, Caputi M and Baldi A: Analysis of HtrA1 serine protease
expression in human lung cancer. Anticancer Res. 26:3455–3459.
2006.PubMed/NCBI
|
|
16
|
Kotliarow Y, Steed ME, Christopher N,
Walling J, Su Q, Center A, Heiss J, Rosenblum M, Mikkelsen T,
Zenklusen JC and Fine HA: High-resolution global genomic survey of
178 gliomas reveals novel regions of copy number alterations and
allelic imbalances. Cancer Res. 66:9428–9436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baldi A, Mottolese M, Vincenzi B, Campioni
M, Mellone P, Di Marino M, di Crescenzo VG, Visca P, Menegozzo S,
Spugnini EP, et al: The serine protease HtrA1 is a novel prognostic
factor for human mesothelioma. Pharmacogenomisc. 9:1069–1077. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oka C, Tsujimoto R, Kajikawa M,
Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soam A,
Kanda H, et al: HtrA1 serine protease inhibits signaling mediated
by Tgfβ family proteins. Development. 131:1041–1053.
2004.PubMed/NCBI
|
|
19
|
Launay S, Maubert E, Lebeurrier A,
Tennstaedt A, Campioni M, Docagne F, Gabriel C, Dauphinot L, Potier
MC, Ehrmann M, et al: HtrA1-dependent proteolysis of TGF-β controls
both neuronal maturation and development survival. Cell Death
Differ. 15:1408–1416. 2008.PubMed/NCBI
|
|
20
|
Inman GJ: Switching TGFβ from a tumor
suppressor to a tumor promoter. Curr Opin Genet Dev. 21:93–99.
2011.
|
|
21
|
Hegde R, Srinivasula SM, Zhang Z, Wassell
R, Mukattash R, Cilenti L, DoBois G, Lazebnik Y, Zevros AS,
Fernandes-Alnemri T and Alnemri ES: Identification of Omi/HtrA2 as
mitochondrial apoptotic serine protease that disrupts inhibitors of
apoptosis protein-caspase interaction. J Biol Chem. 277:432–438.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martins LM, Iaccarino I, Tenev T,
Gschmeissner S, Totty NF, Lemoine NR, Savopoulos J, Gray CW, Creasy
CL, Dingwall C and Downward J: The serine protease Omi/HtrA2
regulates apoptosis by binding XIAP through a reaper-like motif. J
Biol Chem. 277:439–444. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Verhagen AM, Silke J, Ekert PG, Pakusch M,
Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, et al:
HtrA2 promotes cell death through its serine protease activity and
its ability to antagonize inhibitor of apoptosis protein. J Biol
Chem. 277:445–454. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Srinivasula SM, Gupta S, Datta P, Zhang Z,
Hegde R, Cheong N, Fernandes-Alnemri T and Alnemri ES: Inhibitor of
apoptosis proteins are substrates for the mitochondrial serine
protease Omi/HtrA2. J Biol Chem. 278:31469–31472. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang QH, Church-Hajduk R, Ren J, Newton ML
and Du Ch: Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis
(IAP) irreversibly inactivates IAPs and facilitates caspase
activity in apoptosis. Genes Dev. 17:1487–1496. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Seong YM, Choi JY, Park HJ, Kim KJ, Ahn
SG, Seong GH, Kim IK, Kang S and Rhim H: Autocatalytic processing
of HtrA2/Omi is essential for induction of caspase-dependent cell
death through antagonizing XIAP. J Biol Chem. 279:37588–37596.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Trencia A, Fiory F, Maitan MA, Vito P,
Barbagallo AP, Perfetti A, Miele C, Ungaro P, Oriente F, Cilenti L,
et al: Omi/HtrA2 promotes cell death by binding and degrading the
anti-apoptotic protein ped/pea15. J Biol Chem. 279:46566–46572.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cilenti L, Soundarapandrian MM, Kyriasis
GA, Stratico V, Singh S, Gupta S, Bonventre JV, Alnemri ES and
Zervos AS: Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2
protease during cell death. J Biol Chem. 279:50295–50301. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Z, Li H, Derouet M, Berezkin A,
Sasazuki T, Shirasawa S and Rosen K: Oncogenic Ras inhibits anoikis
of intestinal epithelial cells by preventing the release of a
mitochondrial pro-apoptotic protein Omi/HtrA2 into the cytoplasm. J
Biol Chem. 281:14738–14747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Simpson CD, Anyiwe K and Schimmer AD:
Anoikis resistance and tumor metastasis. Cancer Lett. 272:177–185.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nie GY, Li Y, Minoura H, Batten L, Ooi GT,
Findley JK and Salamonsen LA: A novel serine protease of the
mammalian HtrA family is up-regulated in mouse uterus coinciding
with plancentation. Mol Hum Reprod. 9:279–290. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nie GY, Li Y, Hale K, Okada H,
Manuelpillai U, Wallace EM and Salamonsen LA: Serine protease HtrA3
is closely associated with human plancetal development and is
elevated in pregnancy serum. Biol Reprod. 74:366–374. 2006.
View Article : Google Scholar
|
|
33
|
Nie G, Hale K, Li Y, Manuelpillai U,
Wallace EM and Salamonsen LA: Distinct expression and localization
of serine protease HtrA1 in human endometrium and first-trimester
plancenta. Dev Dyn. 235:3448–3455. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nie GY, Hampton A, Li Y, Findlay JK and
Salamonsen LA: Identification and cloning of two isoforms of human
high-temperature requirement factor A3 (HtrA3), characterization of
its genomic structure and comparison of its tissue distribution
with HtrA1 and HtrA2. Biochem J. 371:39–48. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tocharus J, Tsuchiya A, Kajikawa M, Ueta
Y, Oka C and Kawaichi M: Developmentally regulated expression of
Morse HtrA3 and its role as an inhibitor of TGF-β signaling. Dev
Growth Differ. 46:257–274. 2004.PubMed/NCBI
|
|
36
|
Beleford D, Rattan R, Chien J and Shridhar
V: High-temperature requirement A3 (HtrA3) promotes etoposide- and
cisplatin-induced cytotoxicity in lung cancer cell lines. J Biol
Chem. 285:12011–12027. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Beleford D, Liu Z, Rattan R, Quagliuolo L,
Boccellino M, Baldi A, Maguire J, Staub J, Molina J and Shridhar V:
Methylation induced gene silencing of HtrA3 in smoking-related lung
cancer. Cancer Res. 16:398–409. 2010.PubMed/NCBI
|
|
38
|
Lipinska B, Zylicz M and Georgopoulos C:
The HtrA (DegP) protein, essential for Escherichia coli
survival at elevated temperatures, is an endoprotease. J Bacteriol.
172:1791–1797. 1990.PubMed/NCBI
|
|
39
|
Laemmli UK: Cleavage of structural
proteins during assembly of the head of bacteriophage T4. Nature.
227:680–685. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pound JD: Immunochemical protocols.
Methods in Molecular Biology. 80. Walker JM: Humana Press; Totowa,
NJ: 1998, View Article : Google Scholar
|
|
41
|
Zurawa-Janicka D, Kobiela J, Stefaniak T,
Wozniak A, Narkiewicz J, Limon J, Wozniak M and Lipinska B: Changes
in expression of HtrA1 and HtrA2 serine proteases during
estrogen-induced oxidative stress and nephrocarcinogenesis in male
Syrian hamster. Acta Biochem Polon. 55:9–19. 2008.PubMed/NCBI
|
|
42
|
Hu XY, Xu YM, Chen XC, Ping H, Chen ZH and
Zeng FQ: Immunohistochemical analysis of Omi/HtrA2 expression in
prostate cancer and benign prostatic hyperplasia. Acta Pathol
Microbiol Immunol Scand. 114:893–898. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lee SH, Lee JW, Kim HS, Kim SY, Park WS,
Kim SH, Lee JY and Yoo NJ: Immunohistochemical analysis of
Omi/HtrA2 expression in stomach cancer. APMIS. 111:586–590. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bhattacharjee A, Richards WG, Staunton J,
Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et
al: Classification of human lung carcinomas by mRNA expression
profiling reveals distinct adenocarcionomas subclasses. Proc Natl
Acad Sci USA. 98:13790–13795. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stearman RS, Dwyer-Nield L, Zerbe L,
Blaine SA, Chan Z, Bunn PA, Johnson GL, Hirsch FR, Merrick DT,
Franklin WA, et al: Analysis of orthologous gene expression between
human pulmonary adenocarcinoma and a carcinogen-induced murine
model. Am J Pathol. 167:1763–1775. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sorlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sorlie T, Tibshirani R, Parker J, Hastie
T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et
al: Repeated observation of breast tumor subclasses in independent
gene expression data sets. Proc Natl Acad Sci USA. 100:8418–8423.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Handkiewecz-Junak D, Czarniecka A and
Jarzab B: Molecular prognostic markers in papillary and follicular
thyroid cancer: current status and future directions. Mol Cell
Endocrinol. 322:8–28. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chien J, Ota T, Aletti G, Shridhar R,
Boccellino M, Quagliuolo L, Baldi A and Shridhar V: Serine protease
HtrA1 associates with microtubules and inhibits cell migration. Mol
Cell Biol. 29:4177–4187. 2009. View Article : Google Scholar : PubMed/NCBI
|
